Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
/in Breast Cancer, Hyperthermia, International Publications /von 2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
/in Breast Cancer, Hyperthermia, International Publications /von 2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8Natural and therapy-induced immunosurveillance in breast cancer
/in Breast Cancer, International Publications /von 2015-10-01 / Nat. Med. 2015 Oct;21(10):1128-38Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2015-08-27 / 2016 Feb;5(2):e1078057Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)
/in Breast Cancer, Dendritic Cells, International Publications /von 2015-08-13 / Clin Transl Oncol 2016 Jan;18(1):82-7Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
/in Breast Cancer, Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2015-06-02 / Front Immunol 2015;6:271Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de